Naibin Yang1,2, Yuefei Shen3, Chunwei Shi3, Ada Hoi Yan Ma4, Xie Zhang5, Xiaomin Jian6, Liping Wang1, Jiejun Shi1, Chunyang Wu1, Guoxiang Li1, Yuan Fu7, Keyin Wang8, Mingqin Lu2, Guoqing Qian9. 1. Department of Infection and Liver Diseases, Ningbo First Hospital, Ningbo, China. 2. Department of Infection and Liver Diseases, The first affiliated hospital of Wenzhou Medical University, Wenzhou, China. 3. Department of Infectious Diseases, Xiaoshan First People's Hospital, Xiaoshan, China. 4. Nottingham University Business School, University of Nottingham, Ningbo, China. 5. Department of Pulmon.ary and Critical Care Medicine, Yueqing people's Hospital, Yueqing, China. 6. Department of Radiology, Beijing Fuxing Hospital, Affiliated to Capital University of Medical Science, Beijing, China. 7. Department of Radiology, Ningbo First Hospital, Ningbo, China. 8. Department of Infection and Liver Diseases, The First Hospital of Jiaxing City, Jiaxing, China. 9. Department of General Internal Medicine, Ningbo First Hospital, Ningbo, China.
Abstract
BACKGROUND: No data is available about in-flight transmission of SARS-CoV-2. Here, we report an in-flight transmission cluster of COVID-19 and describe the clinical characteristics of these patients. METHODS: After a flight, laboratory-confirmed COVID-19 was reported in 12 patients. Ten patients were admitted to the designated hospital. Data was collected from 25th January to 28th February 2020. Clinical information was retrospectively collected. RESULTS: All patients were passengers, and none were flight attendants. The median age was 33 years, and 70% were females. None was admitted to intensive care unit, and no patients died up to 28th February. The median incubation period was 3.0 days and time from onset of illness to hospital admission was 2 days. The most common symptom was fever. Two patients were asymptomatic and had normal chest CT scan during hospital stay. On admission, initial RT-PCR was positive in 9 patients, and initial chest CT was positive in half of the patients. The median lung 'total severity score' of chest CT was 6. 'Crazy-paving' pattern, pleural effusion, and ground-glass nodules were seen. CONCLUSION: There is potential for COVID-19 transmission in aeroplanes, but the symptoms were mild in our patients. Passengers and attendants must be protected during flights.
BACKGROUND: No data is available about in-flight transmission of SARS-CoV-2. Here, we report an in-flight transmission cluster of COVID-19 and describe the clinical characteristics of these patients. METHODS: After a flight, laboratory-confirmed COVID-19 was reported in 12 patients. Ten patients were admitted to the designated hospital. Data was collected from 25th January to 28th February 2020. Clinical information was retrospectively collected. RESULTS: All patients were passengers, and none were flight attendants. The median age was 33 years, and 70% were females. None was admitted to intensive care unit, and no patientsdied up to 28th February. The median incubation period was 3.0 days and time from onset of illness to hospital admission was 2 days. The most common symptom was fever. Two patients were asymptomatic and had normal chest CT scan during hospital stay. On admission, initial RT-PCR was positive in 9 patients, and initial chest CT was positive in half of the patients. The median lung 'total severity score' of chest CT was 6. 'Crazy-paving' pattern, pleural effusion, and ground-glass nodules were seen. CONCLUSION: There is potential for COVID-19 transmission in aeroplanes, but the symptoms were mild in our patients. Passengers and attendants must be protected during flights.
Authors: Inessa Markus; Gyde Steffen; Raskit Lachmann; Adine Marquis; Timm Schneider; Sara Tomczyk; Uwe Koppe; Anna M Rohde; Susanne Barbara Schink; Janna Seifried; Teresa Domaszewska; Ute Rexroth; Maria An der Heiden Journal: Euro Surveill Date: 2021-03
Authors: Rachel M Burke; Laura Calderwood; Marie E Killerby; Candace E Ashworth; Abby L Berns; Skyler Brennan; Jonathan M Bressler; Laurel Harduar Morano; Nathaniel M Lewis; Tiffanie M Markus; Suzanne M Newton; Jennifer S Read; Tamara Rissman; Joanne Taylor; Jacqueline E Tate; Claire M Midgley Journal: Emerg Infect Dis Date: 2021-06-30 Impact factor: 6.883